These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11342694)

  • 1. Differentiation between reactive gliosis and diffuse astrocytoma by in situ hybridization.
    Wessels PH; Hopman AH; Ummelen MI; Krijne-Kubat B; Ramaekers FC; Twijnstra A
    Neurology; 2001 May; 56(9):1224-7. PubMed ID: 11342694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of chromosomal changes by interphase cytogenetics in biopsies of recurrent astrocytomas and oligodendrogliomas.
    Rosso SM; van Dekken H; Krishnadath KK; Alers JC; Kros JM
    J Neuropathol Exp Neurol; 1997 Oct; 56(10):1125-31. PubMed ID: 9329456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interphase cytogenetic (in situ hybridization) analysis of astrocytomas using archival, formalin-fixed, paraffin-embedded tissue and nonfluorescent light microscopy.
    Perry A; Tonk V; McIntire DD; White CL
    Am J Clin Pathol; 1997 Aug; 108(2):166-74. PubMed ID: 9260757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear overexpression of urocortin discriminates primary brain tumors from reactive gliosis.
    Tsai WC; Hueng DY; Lin CK
    APMIS; 2015 Jun; 123(6):465-72. PubMed ID: 25904177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gain of chromosome 7, as detected by in situ hybridization, strongly correlates with shorter survival in astrocytoma grade 2.
    Wessels PH; Twijnstra A; Kessels AG; Krijne-Kubat B; Theunissen PH; Ummelen MI; Ramaekers FC; Hopman AH
    Genes Chromosomes Cancer; 2002 Mar; 33(3):279-84. PubMed ID: 11807985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of EGFR and PTEN numerical aberrations in the evaluation of diffusely infiltrating astrocytomas. Laboratory investigation.
    Mott RT; Turner KC; Bigner DD; McLendon RE
    J Neurosurg; 2008 Feb; 108(2):330-5. PubMed ID: 18240930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitive and specific diagnostic panel to distinguish diffuse astrocytoma from astrocytosis: chromosome 7 gain with mutant isocitrate dehydrogenase 1 and p53.
    Camelo-Piragua S; Jansen M; Ganguly A; Kim JC; Cosper AK; Dias-Santagata D; Nutt CL; Iafrate AJ; Louis DN
    J Neuropathol Exp Neurol; 2011 Feb; 70(2):110-5. PubMed ID: 21343879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grade II astrocytomas are subgrouped by chromosome aberrations.
    Hirose Y; Aldape KD; Chang S; Lamborn K; Berger MS; Feuerstein BG
    Cancer Genet Cytogenet; 2003 Apr; 142(1):1-7. PubMed ID: 12660025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Numerical aberrations of chromosomes 1, 2, and 7 in astrocytomas studied by interphase cytogenetics.
    Wernicke C; Thiel G; Lozanova T; Vogel S; Witkowski R
    Genes Chromosomes Cancer; 1997 May; 19(1):6-13. PubMed ID: 9135989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of fluorescence in situ hybridization to detect loss of chromosome 10 in astrocytomas.
    Dalrymple SJ; Herath JF; Ritland SR; Moertel CA; Jenkins RB
    J Neurosurg; 1995 Aug; 83(2):316-23. PubMed ID: 7616278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic analysis of gliomas by in situ hybridization of stereotactic biopsy material.
    Lippitz BE; Scheitinger C; Scholz M; Weis J; Gilsbach JM; Füzesi L
    Acta Neurochir (Wien); 1997; 139(1):22-5. PubMed ID: 9059707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic and molecular cytogenetic analyses in diffuse astrocytomas.
    Krupp W; Geiger K; Schober R; Siegert G; Froster UG
    Cancer Genet Cytogenet; 2004 Aug; 153(1):32-8. PubMed ID: 15325091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas.
    Kitange G; Misra A; Law M; Passe S; Kollmeyer TM; Maurer M; Ballman K; Feuerstein BG; Jenkins RB
    Genes Chromosomes Cancer; 2005 Jan; 42(1):68-77. PubMed ID: 15472895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the silver nucleolar organizer region (AgNOR) technique in the differential diagnosis of central nervous system neoplasia.
    Louis DN; Meehan SM; Ferrante RJ; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1992 Mar; 51(2):150-7. PubMed ID: 1538239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor tyrosine kinase expression in astrocytic lesions: similar features in gliosis and glioma.
    Kristt DA; Reedy E; Yarden Y
    Neurosurgery; 1993 Jul; 33(1):106-15. PubMed ID: 7689190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDC25B, Ki-67, and p53 expressions in reactive gliosis and astrocytomas.
    Suren D; Isiksacan Ozen O
    J BUON; 2013; 18(4):1006-11. PubMed ID: 24344030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonrandom chromosomal gains in pilocytic astrocytomas of childhood.
    White FV; Anthony DC; Yunis EJ; Tarbell NJ; Scott RM; Schofield DE
    Hum Pathol; 1995 Sep; 26(9):979-86. PubMed ID: 7672798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A complex rearrangement of chromosome 7 in human astrocytoma.
    Misra A; Pellarin M; Shapiro JR; Feuerstein BG
    Cancer Genet Cytogenet; 2004 Jun; 151(2):162-70. PubMed ID: 15172755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of cell cycle regulators in gliomatosis cerebri.
    Mawrin C; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Mawrin A; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Mawrin A; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Mawrin A; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Deimling A; Stoltenburg-Didinge G; Bornemann A; Romeike B; Sellhaus B; Dietzmann K
    J Neurooncol; 2005 Apr; 72(2):115-22. PubMed ID: 15925990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.
    Brat DJ; Seiferheld WF; Perry A; Hammond EH; Murray KJ; Schulsinger AR; Mehta MP; Curran WJ;
    Neuro Oncol; 2004 Apr; 6(2):96-103. PubMed ID: 15134623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.